Cardio-hepatic interactions are poorly understood yet play a critical role in the pathophysiology of HFpEF where aberrant metabolic signaling pathways such as insulin resistance, inflammation and ...

Background: Heart failure with preserved ejection fraction (HFpEF) is among the leading causes of cardiovascular mortality and morbidity. Recent multi-omics data sets underscore severely impaired ...

About half of all people with heart failure have a heart that pumps normally—or at near-normal levels. Heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure, ...

Talk to your provider about your risks and work together on lowering them. Centers for Disease Control and Prevention. Deaths: Leading causes for 2021. U.S. Department of Transportation National ...

Opens in a new tab or window The novel investigational weight loss agent HU6 had mixed results specifically targeting obesity-related heart failure with preserved ejection fraction (HFpEF), based ...

Once-weekly semaglutide (Wegovy; Novo Nordisk) improves outcomes in patients who have obesity-related heart failure with preserved ejection fraction (HFpEF) across subgroups defined by baseline ...

In later stages of the condition, your body may also not produce enough insulin. There are several possible causes of diabetes, and it’s usually a combination of factors rather than just one.

Changes to derivation of Indigenous status for deaths in ABS mortality datasets ...

The novel investigational weight loss agent HU6 had mixed results specifically targeting obesity-related heart failure with preserved ejection fraction (HFpEF), based on the small HuMain-HFpEF trial.

Discuss the data presented at European Society of Cardiology Congress 2024 on β-blocker (βB) use and outcomes in patients with heart failure with midrange ejection fraction (HFmrEF) and HF with ...